Cite
APA Citation
Kopruszinski, C. M., Thornton, P., Arnold, J., Newton, P., Lowne, D., Navratilova, E., Swiokla, J., Dodick, D. W., Dobson, C., Gurrell, I., Chessell, I. P., & Porreca, F. (2020). characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine. Cephalalgia, 40, 1535–1550. http://access.bl.uk/ark:/81055/vdc_100110629999.0x00002d